AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. FORM OF NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • November 13th, 2023 • 10X Capital Venture Acquisition Corp. III • Blank checks • Delaware
This Note And Warrant Purchase Agreement (the “Agreement”) is made as of February 14, 2019 (the “Effective Date”) by and among American Gene Technologies International Inc., a Delaware corporation (the “Company”), and the persons and entities named on the Schedule of Purchasers attached hereto (individually, a “Purchaser” and collectively, the “Purchasers”).
Senior Secured Convertible Promissory NOTE PURCHASE AGREEMENTSenior Secured Convertible Promissory Note Purchase Agreement • November 13th, 2023 • 10X Capital Venture Acquisition Corp. III • Blank checks • Delaware
THIS Secured Convertible Promissory NOTE PURCHASE AGREEMENT (as amended and/or restated from time to time, this “Agreement”), is made as of October 31, 2023 by and between American Gene Technologies International Inc., a Delaware corporation (the “Company”), and each of the individuals and entities listed on Exhibit A attached to this Agreement (each an “Investor” and together the “Investors”).
SECURITY AGREEMENTSecurity Agreement • November 13th, 2023 • 10X Capital Venture Acquisition Corp. III • Blank checks • Delaware
This Security Agreement (as amended, modified or otherwise supplemented from time to time, this “Security Agreement”), dated as of October 31, 2023, is executed by American Gene Technologies International Inc., a Delaware corporation (together with its successors and assigns, the “Company”), in favor of Wilmington Trust, National Association, as collateral agent (in such capacity together with its successors in such capacity, the “Collateral Agent”) on behalf of the Investors listed on the signature pages hereof.
INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • November 13th, 2023 • 10X Capital Venture Acquisition Corp. III • Blank checks • Delaware
This Intellectual Property Security Agreement (“Agreement”) is executed on October 31, 2023 by American Gene Technologies International Inc., a Delaware corporation (together with its successors and assigns, “Grantor”), in favor of Wilmington Trust, National Association, a national banking association, as collateral agent (in such capacity, together with its successors in such capacity, the “Collateral Agent”) on behalf of the Investors listed on the signature pages hereof.
